A Socio-ecological Approach for Improving Self-management in Adolescents With SCD

Conditions

• Anemia, Sickle Cell

Eligibility Criteria

Sex

ALL

Age

13 Years - 21 Years

Healthy Volunteers

Not accepted

Interventions

• SCThrive — BEHAVIORAL
  SCThrive is a virtual, 8-week, virtual group-based, behavioral self-management intervention that includes daily use of a companion mobile app.
• SCHealthED — OTHER
  Standard of care plus 7 SCD educational text messages to ensure education is uniform across sites

Study Details

The goal of this clinical trial is to evaluate the impact of SCThrive (a behavioral self-management intervention) on patient activation, self-management behaviors, daily functioning, and emergency room visits in 260 adolescents and young adults with sickle cell disease (SCD) ages 13-21 receiving care at 1 of 4 pediatric SCD clinics. The main question\[s\]it aims to answer are: * Does SCThrive improve patient activation? * Does SCThrive improve self-management behaviors, daily functioning, and decrease emergency room visits? * Are any improvements maintained 3 months after treatment? Participants will complete self-management related surveys before, after, and 3 months following their participation in an 8- week, virtual group intervention with an accompanying mobile app (SCThrive). Researchers will compare outcomes for participants who receive SCThrive and participants who receive uniform standard care (SCHealthED which = standard of care plus SCD educational text messages) to see if there are differences in patient activation, self-management behaviors, daily functioning, and emergency room visits.

Key Dates

Start date

Feb 3, 2025

Status verified

May 2026

Primary completion

Jan 31, 2028

Completion

Jun 30, 2028

Study Design

Enrollment

310 participants (estimated)

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Arms

• Active Comparator: Active Treatment
  SCThrive is a virtual, 8-week, virtual group-based, behavioral self-management intervention that includes daily use of a companion mobile app.
• Placebo Comparator: Control Condition
  Participants randomized to SCHealthED will receive usual care plus 7 text messages consisting of SCD educational facts to ensure the care is uniform across sites.

Primary Outcome Measure

Patient Activation [ Time Frame: baseline, up to 4 weeks after treatment ends, 3 to 4 months after treatment ends ]

Central Contacts

• Ama Wilson, MPH
  15136365380
  [email protected]
• Taylor Richardson, BA
  [email protected]

Locations (4)

Find similar trials in Wilmington, DE

Related Studies

• A Study to Evaluate BMS-986470 in Healthy Volunteers and Participants With Sickle Cell Disease
  PHASE1/PHASE2 · Recruiting · Bristol-Myers Squibb · Birmingham, Alabama
• Metabolic and Hemodynamic Reserve in Pediatric SCA
  Recruiting · Washington University School of Medicine · St Louis, Missouri